Fingerprint
Dive into the research topics of 'A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically